Form 4: Accolade Inc. Director Jeffrey S. Brodsky Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Jeffrey S. Brodsky reports acquisition of 6,245 Restricted Stock Units (RSUs) in Accolade, Inc. on March 3, 2025, vesting quarterly over one year.

Summary

  • On March 3, 2025, Jeffrey S. Brodsky, a director of Accolade, Inc., acquired 6,245 Restricted Stock Units (RSUs).
  • These RSUs represent a contingent right to receive one share of Accolade's Common Stock each.
  • The RSUs will vest at a rate of 25% each quarter, starting from March 1, 2025, provided continuous service is maintained.
  • Full vesting will occur on the one-year anniversary of the Vesting Commencement Date.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock unit acquisition. The vesting schedule suggests a long-term commitment from the director.

Positives

  • The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest over a one-year period contingent on continuous service, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

  • Shareholders may view the acquisition of RSUs by a director as a positive sign, indicating confidence in the company's future.

Key Dates

DateDescription
03/01/2025Vesting Commencement Date
03/03/2025Transaction Date: Acquisition of Restricted Stock Units
03/05/2025Date of Form 4 Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.